An ultrasound joint venture between Shanghai Medical ElectronicsInstrument Factory (SMEIF) and Ausonics of Sidney was revitalizedlate last year when the Chinese government granted approval forlocal assembly and sales. The venture was almost aborted two
An ultrasound joint venture between Shanghai Medical ElectronicsInstrument Factory (SMEIF) and Ausonics of Sidney was revitalizedlate last year when the Chinese government granted approval forlocal assembly and sales.
The venture was almost aborted two years ago by political tensionsand pressure from Chinese ultrasound vendors, said Kerrie Tarrant,Ausonics international marketing manager.
SMEIF staff is being trained in Shanghai and Australia forassembly of the Ausonics MI2000 scanner and probes in Shanghai,she said.
The two companies have skipped the planned first stage of cooperation,which called for importing complete scanners and providing clinicaltraining in China. Instead, they are initiating local assembly,technology transfer and marketing of systems. This process willcontinue through 1991, Tarrant said.
The Australian government is providing low-interest exportfinancing to the Chinese, which has helped Ausonics bypass limitationson foreign exchange availability. All of the ultrasound systemswill be sold in China, initially for women's health/family planningpurposes, Tarrant said.
The next stage of the venture should involve a broader rangeof clinical applications, both in terms of ultrasound technologytransfer and scanner marketing efforts, she said.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.